600420 国药现代
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.6666.0986.6446.7968.255
总资产报酬率 ROA (%)3.6543.5503.2443.0453.616
投入资产回报率 ROIC (%)4.9074.7704.5274.3695.083

边际利润分析
销售毛利率 (%)39.63138.32638.07943.72147.076
营业利润率 (%)18.4018.9617.4556.4368.157
息税前利润/营业总收入 (%)17.1958.4607.2387.3029.569
净利润/营业总收入 (%)14.8807.9926.6945.8887.168

收益指标分析
经营活动净收益/利润总额(%)94.00297.60193.010113.71095.189
价值变动净收益/利润总额(%)1.5502.5040.238-2.618-2.095
营业外收支净额/利润总额(%)-0.9481.3621.8272.2491.626

偿债能力分析
流动比率 (X)2.4582.8202.7851.5911.641
速动比率 (X)1.9672.2162.2031.1421.111
资产负债率 (%)24.44225.90938.09245.62246.197
带息债务/全部投入资本 (%)11.25612.50627.27732.13035.019
股东权益/带息债务 (%)773.796688.287258.420203.870180.054
股东权益/负债合计 (%)265.783247.072137.81798.76696.443
利息保障倍数 (X)-16.648-13.525-20.33410.1807.493

营运能力分析
应收账款周转天数 (天)40.93548.22258.16251.20439.380
存货周转天数 (天)113.933114.136123.644145.722151.674